Skip to the content
Neurodexlogo darklogo light
  • Home
  • About Us
    • Our Team
    • Neurodex Laboratories
    • Neurodex Brochures
  • Our Tech
    • ExoSort Platform
    • Our Projects
    • Publications
    • Pipeline
  • Services
    • Neurodiagnostic Platform
    • Research Services
    • ⁠Pre-Clinical Services
    • Clinical Trial Services
  • NeuroDex News
  • Contact Us
Neurodexlogo darklogo light
HomePosted by Victoria Akhiezer
Cell signaling and gene expression pathway
Explanation Material

NF-κB: Unraveling the Master Regulator of Immune and Inflammatory Responses

Victoria Akhiezer
February 10, 2026
NeuroDex Powers New Neuron EV RNA-Seq Dataset in AMP PDRD
NeuroDex News

NeuroDex Powers New Neuron EV RNA-Seq Dataset in AMP PDRD

Victoria Akhiezer
February 4, 2026
NeuroDex Contributes to Landmark Review on Tissue-Specific Extracellular Vesicles and the Future of Liquid Biopsy
NeuroDex News

NeuroDex Contributes to Landmark Review on Tissue-Specific Extracellular Vesicles and the Future of Liquid Biopsy

Victoria Akhiezer
February 3, 2026
Amyotrophic Lateral Sclerosis (ALS)
Uncategorized

Amyotrophic Lateral Sclerosis (ALS)

Victoria Akhiezer
January 21, 2026
Next-Generation Biomarkers for Neurodegeneration
Biotech Blog

Next-Generation Biomarkers for Neurodegeneration

Victoria Akhiezer
January 15, 2026
10 Kinds of Dementia
Explanation Material

10 Kinds of Dementia

Victoria Akhiezer
January 5, 2026
Huntington's Disease Latest Research, Biomarker Discoveries, and Promising Treatments
Biotech Blog

Huntington’s Disease Latest Research, Biomarker Discoveries, and Promising Treatments

Victoria Akhiezer
January 4, 2026
Neurodex 2025: Advancing ALS Biomarker Discovery for Better Outcomes
NeuroDex News

Neurodex 2025: Advancing ALS Biomarker Discovery for Better Outcomes

Victoria Akhiezer
December 24, 2025
Alpha-Synuclein Seed Amplification Assays
Biotech Blog

Alpha-Synuclein Seed Amplification Assays: The Game-Changer for Early PD Detection and Clinical Trial Stratification

Victoria Akhiezer
November 20, 2025
Latest Advances in Parkinson's Clinical Trials
Biotech Blog

Latest Advances in Parkinson’s Clinical Trials

Victoria Akhiezer
November 19, 2025

Posts pagination

1 2 3 4

Contact Us

Company

NeuroDex Inc

  • 22 Strathmore Road
  • Natick, MA US 01760
  • info@neurodex.co
Information
  • Terms & Conditions
  • Privacy Policy
  • Neurodex FAQ
Resources
  • Explanation Material
  • NeuroDex News
  • Blog
Back to top Drag
  • Home
  • About Us
    • Our Team
    • Neurodex Laboratories
    • Neurodex Brochures
  • Our Tech
    • ExoSort Platform
    • Our Projects
    • Publications
    • Pipeline
  • Services
    • Neurodiagnostic Platform
    • Research Services
    • ⁠Pre-Clinical Services
    • Clinical Trial Services
  • NeuroDex News
  • Contact Us
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}